Randolph E. Regal

University of Michigan–Ann Arbor — United States

Medicine · Health Sciences

18h-index1.1kcitations47works9.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease and Transplantation(8), Microscopic Colitis(8), Inflammatory Bowel Disease(6), Liver Disease Diagnosis and Treatment(5), Venous Thromboembolism Diagnosis and Management(4)

Publications47 total

Pharmacologic Management of Anticoagulation in Patients with Hepatic Cirrhosis: A Review of Dosing and Monitoring Strategies
Therapeutics·2025· 1 citedOpen Access
Sa1915: SEQUENTIAL INFLIXIMAB AND JANUS KINASE INHIBIOR SALVAGE THERAPY FOR PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS: A MULTICENTER EXPERIENCE
Gastroenterology·2025
Treatment of Pain in Cirrhosis: Advice to Caregivers of Those with Rock Livers
Clinical Therapeutics·2024
Tu1828 EFFECTIVENESS OF UPADACITINIB FOR PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS: A CASE-CONTROL STUDY
Gastroenterology·2024
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience
The American Journal of Gastroenterology·2024· 46 citedOpen Access
Tu1769 OFF-LABEL, HIGH-INTENSITY UPADACITINIB FOR HOSPITALIZED PATIENTS WITH SEVERE INFLAMMATORY BOWEL DISEASE
Gastroenterology·2023· 2 citedOpen Access
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study
Clinical Gastroenterology and Hepatology·2021· 121 citedOpen Access
Incorporating preauthorization into antimicrobial stewardship pharmacist workflow reduces <i>Clostridioides difficile</i> and gastrointestinal panel testing
Infection Control and Hospital Epidemiology·2020· 12 cited
Cirrhosis, Thrombosis, Finding FaXts about Doses: Dosing of Unfractionated Heparin for Venous Thromboembolism in Cirrhosis
Annals of Pharmacotherapy·2019· 2 cited
Routine Use of Vitamin K in the Treatment of Cirrhosis-Related Coagulopathy: Is it A-O-K? Maybe Not, We Say.
PubMed·2019· 18 cited
P044 EFFICACY OF INDUCTION THERAPY WITH HIGH-INTENSITY TOFACITINIB IN 4 PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS
Inflammatory Bowel Diseases·2019· 1 cited
P044 EFFICACY OF INDUCTION THERAPY WITH HIGH-INTENSITY TOFACITINIB IN 4 PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS
Gastroenterology·2019
Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis
Clinical Gastroenterology and Hepatology·2018· 104 citedOpen Access
Evaluation of Vancomycin Dosing in Patients With Cirrhosis: Beginning De-Liver-ations about a New Nomogram
Hospital Pharmacy·2018· 7 cited
Dosing of Enoxaparin in Renal Impairment.
PubMed·2017· 25 cited
Cockcroft-Gault revisited: New de-liver-ance on recommendations for use in cirrhosis
World Journal of Hepatology·2017· 18 citedOpen Access
Anticoagulation in Patients With Cirrhosis
Annals of Pharmacotherapy·2016· 39 cited
Do SSRI Antidepressants Increase The Risk of Extrapyramidal Side Effects In Patients Taking Antipsychotics?
PubMed·2016· 7 citedOpen Access
Daclatasvir
Annals of Pharmacotherapy·2015· 60 cited
Valproic Acid as a potentiator of metabolic syndrome in institutionalized residents on concomitant antipsychotics: fat chance, or slim to none?
PubMed·2015· 23 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jeffrey Berinstein(8), Shrinivas Bishu(8), Peter Higgins(8), Calen A. Steiner(7), Elliot Berinstein(5), Ryan W. Stidham(5), Shirley Cohen‐Mekelburg(5), Jami Kinnucan(4), Akbar K. Waljee(4), Cesar Alaniz(4), H Serre(4), Jessica L. Sheehan(3), John I. Allen(3), Daryl D. DePestel(3), Taylor A. Karl(3), Terrence A. Barrett(3), Waseem Ahmed(3), Jake Levine(3), Syed Adeel Hassan(3), Courtney Perry(3)